https://pmc.ncbi.nlm.nih.gov/articles/PMC3778773/
Rebamipide: A Novel Agent in the Treatment of Recurrent Aphthous Ulcer and Behcet's Syndrome - PMC
Rebamipide is an amino acid analog of 2 (1H)-quinolinone. It is being introduced and used since 1980 for the treatment of peptic ulcer. Its therapeutic use in...
https://www.researchandmarkets.com/report/rebamipide
Rebamipide (CAS 90098-04-7) Industry Research 2025
Rebamipide (CAS 90098-04-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029
04 7industry researchrebamipidecas2025
https://pmc.ncbi.nlm.nih.gov/articles/PMC6780189/
Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for Helicobacter pylori...
Background: There has been a negative trend in the effectiveness of classic eradication therapy regimens for Helicobacter pylori (H. pylori), which has largely...
of theefficiencyinclusionrebamipide
https://www.ncbi.nlm.nih.gov/Structure/pdb/8U5M
8U5M: Structure of Sts-1 HP domain with rebamipide
Ubiquitin-associated and SH3 domain-containing protein BRebamipide
sts 1structurehpdomainrebamipide